搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
10 天
AHA 2024: CKD patients could benefit from an aldosterone synthase inhibitor
An ageing global population increases the prevalence of CKD, leading to market expansion and a growing need for treatment ...
Daily
3 小时
Melatonin Supplementation Shows Promise for Managing Diabetic CKD: A New Randomized Trial ...
Iran: A new study published in the BMC journal Trials is exploring the potential benefits of melatonin supplementation for ...
Medpage Today on MSN
3 天
Study: CKD Not Worsened With Gout Treatment
Some 20% to 30% of gout patients also have CKD, the researchers said, which is not surprising since they share many risk ...
9 天
AHA 2024: GLP-1R agonist associated with better clinical outcomes in heart failure and CKD
Real-world data on GLP-1R agonists’ safety in heart failure and CKD patients was investigated using the TriNetX Research ...
Renal & Urology News
2 天
CKD Tied to Worse Outcomes After LAAO Device Implantation for Atrial Fibrillation
The safety of left atrial appendage occlusion (LAAO) device implantation in patients with CKD has been uncertain and tied with complications.
9 天
AHA 2024: semaglutide continues to impress in diabetic kidney disease
KOLs interviewed by GlobalData think that semaglutide can be a treatment option for non-diabetic CKD patients whose kidney ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈